Transforming growth factor-β1 increases bad phosphorylation and protects neurons against damage

被引:223
|
作者
Zhu, Y
Yang, GY
Ahlemeyer, B
Pang, L
Che, XM
Culmsee, C
Klumpp, S
Krieglstein, J
机构
[1] Univ Marburg, Inst Pharmakol & Toxikol, D-35032 Marburg, Germany
[2] Univ Marburg, Inst Pharmazeut Chem, D-35032 Marburg, Germany
[3] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA
来源
JOURNAL OF NEUROSCIENCE | 2002年 / 22卷 / 10期
关键词
TGF-beta; 1; neuroprotection; MAPK/Erk signaling; Bad phosphorylation; cerebral ischemia; rat hippocampal cells;
D O I
10.1523/JNEUROSCI.22-10-03898.2002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Despite the characterization of neuroprotection by transforming growth factor-beta1 (TGF-beta1), the signaling pathway mediating its protective effect is unclear. Bad is a proapoptotic member of the Bcl-2 family and is inactivated on phosphorylation via mitogen-activated protein kinase (MAPK). This study attempted to address whether MAPK signaling and Bad phosphorylation were influenced by TGF-beta1 and, furthermore, whether these two events were involved in the antiapoptotic effect of TGF-beta1. We found a gradual activation of extracellular signal-regulated kinase 1/2 (Erk1/2) and MAPK-activated protein kinase-1 (also called Rsk1) and a concomitant increase in Bad phosphorylation at Ser(112) in mouse brains after adenovirus-mediated TGF-beta1 transduction under nonischemic and ischemic conditions induced by transient middle cerebral artery occlusion. Consistent with these effects, the ischemia-induced increase in Bad protein level and caspase-3 activation were suppressed in TGF-beta1-transduced brain. Consequently, DNA fragmentation, ischemic lesions, and neurological deficiency were significantly reduced. In cultured rat hippocampal cells, TGF-beta1 inhibited the increase in Bad expression caused by staurosporine. TGF-beta1 concentration- and time-dependently activated Erk1/2 and Rsk1 accompanied by an increase in Bad phosphorylation. These effects were blocked by U0126, a mitogen-activated protein kinase/Erk kinase 1/2 inhibitor, suggesting an association between Bad phosphorylation and MAPK activation. Notably, U0126 and a Rsk1 inhibitor (Ro318220) abolished the neuroprotective activity of TGF-beta1 in staurosporine-induced apoptosis, indicating that activation of MAPK is necessary for the antiapoptotic effect of TGF-beta1 in cultured hippocampal cells. Together, we demonstrate that TGF-beta1 suppresses Bad expression under lesion conditions, increases Bad phosphorylation, and activates the MAPK/Erk pathway, which may contribute to its neuroprotective activity.
引用
收藏
页码:3898 / 3909
页数:12
相关论文
共 50 条
  • [1] Transforming growth factor-β, 'bad' or 'good'?
    Minoo, P.
    Ramanathan, R.
    NEONATOLOGY, 2008, 93 (04) : 333 - 334
  • [2] Latent Transforming Growth Factor-β1 Protects against Bleomycin-Induced Lung Injury in Mice
    Tang, Yong-Jiang
    Xiao, Jun
    Huang, Xiao Ru
    Zhang, Yang
    Yang, Chen
    Meng, Xiao-Ming
    Feng, Yu-Lin
    Wang, Xiao-Jing
    Hui, David S. C.
    Yu, Cheuk-Man
    Lan, Hui Yao
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2014, 51 (06) : 761 - 771
  • [3] Transforming Growth Factor-β1 Increases Lethality of Total Body Irradiation
    Kumar, S.
    Kolozsvary, A.
    Kim, J.
    Brown, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S168 - S169
  • [4] Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-β1 pathway
    Lee, H. Thomas
    Chen, Sean W. C.
    Doetschman, Thomas C.
    Deng, Chuxia
    D'Agati, Vivette D.
    Kim, Mihwa
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2008, 295 (01) : F128 - F136
  • [5] TRANSFORMING GROWTH FACTOR-β1 PROTECTS AGAINST INTESTINAL EPITHELIAL BARRIER DYSFUNCTION CAUSED BY HYPOXIA-REOXYGENATION
    Howe, Kathryn L.
    Lorentz, Robert J.
    Assa, Amit
    Pinnell, Lee J.
    Johnson-Henry, Kathene C.
    Sherman, Philip M.
    SHOCK, 2015, 43 (05): : 483 - 489
  • [6] Klotho overexpression protects against renal aging along with suppression of transforming growth factor-β1 signaling pathways
    Oishi, Hiroaki
    Doi, Shigehiro
    Nakashima, Ayumu
    Ike, Takeshi
    Maeoka, Yujiro
    Sasaki, Kensuke
    Doi, Toshiki
    Masaki, Takao
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2021, 321 (06) : F799 - F811
  • [7] Transforming growth factor-β1 in sarcoidosis
    Salez, F
    Gosset, P
    Copin, MC
    Degros, CL
    Tonnel, AB
    Wallaert, B
    EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (04) : 913 - 919
  • [8] Transforming growth factor-β1 to the bone
    Janssens, K
    ten Dijke, P
    Janssens, S
    Van Hul, W
    ENDOCRINE REVIEWS, 2005, 26 (06) : 743 - 774
  • [9] Differential expression of nerve growth factor transcripts in glia and neurons and their regulation by transforming growth factor-β1
    Yu, GH
    Fahnestock, M
    MOLECULAR BRAIN RESEARCH, 2002, 105 (1-2): : 115 - 125
  • [10] Transforming Growth Factor-β-inducible Phosphorylation of Smad3
    Wang, Guannan
    Matsuura, Isao
    He, Dongming
    Liu, Fang
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (15) : 9663 - 9673